Pasar al contenido principal

NEXT-GENERATION THERAPIES FOR ALZHEIMER’S DISEASE: INNOVATION IN DRUG DESIGN AND DEVELOPMENT

PID2024-157469OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Potent Nrf2-Inducing C6-Isothiocyanate Glucose Derivatives with Dual Antioxidant and Antitumor Activity

  • Prieto Ramírez, Luis Alberto
  • Khiar-Fernández, Nora
  • Calderón-Ruiz, R.
  • Giraud, Emelyne
  • Calderón-Montaño, José Manuel
  • Lucia-Tamudo, Jesús
  • León, Rafael
  • Pérez-Simón, José A.
  • López-Lázaro, Miguel
  • Recio, Rocío
  • Torre-Madrid, Elena de la
  • Valdivia, Victoria
  • Fernández, Inmaculada
This article belongs to the Section Natural and Synthetic Antioxidants., Isothiocyanates (ITCs) are well-known electrophilic agents with antioxidant and anticancer properties, largely attributed to their ability to activate the Nrf2/ARE pathway. Building on previous work with C1-ITC glycosyl derivatives, we designed and synthesized a new series of S-glycosyl isothiocyanates in which the ITC group was repositioned to the C6 carbon of the glucose scaffold. This structural rearrangement yielded stable and synthetically accessible derivatives with markedly enhanced biological profiles. Several compounds showed potent Nrf2 activation at non-cytotoxic concentrations, with CD values comparable to or exceeding those of natural ITCs. In parallel, the new C6-ITC derivatives displayed significant antiproliferative activity against leukemia and solid tumor cell lines. Among them, the phenylsulfone derivative 13 emerged as a particularly promising dual-action molecule, combining strong Nrf2 induction with low-micromolar cytotoxicity. Molecular docking was used as a hypothesis-generating approach and suggested a possible interaction with the STAT3 SH2 domain, although further studies are needed to validate this target. Overall, these results support glucose-based ITCs as a versatile platform for the development of multifunctional antioxidants with complementary anticancer properties., This publication is part of the project PID2022-138863OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU., This work is part of the projects: PID2022-138863OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU (to I.F.); PID2021-123481OB-I00 and PID2024-157469OB-I00 (to R.L.) and P2022/BMD-7230-CAM-22 (to R.L.). The US (University of Seville) is also acknowledged for the support provided through its own research plan (VII PPIT-US). We gratefully thank the Centre of Research Technology and Innovation of the University of Seville (CITIUS) for NMR facilities. During the preparation of this work, the author(s) used Gemini and ChatGPT 5.2 in order to optimize the semantic coherence of the sentences and ensure their grammatical and stylistic accuracy in the English language, thereby guaranteeing the utmost clarity and precision in the ex-pression of the intended ideas. After using this tool/service, the authors reviewed and edited the content as needed and takes full responsibility for the content of the published article., Peer reviewed